Left Atrial Appendage Closure

  • Stefan C. Bertog
  • Jennifer Franke
  • Nina Wunderlich
  • Horst Sievert


Atrial fibrillation is associated with a significant stroke risk. Though anticoagulation with warfarin reduces this risk, it also increases the likelihood of bleeding including intracranial hemorrhage and requires meticulous patient compliance and monitoring. Alternative anticoagulants have recently been demonstrated to be at least equivalent to warfarin but are accompanied by a similar bleeding risk. Therefore, the concept of percutaneous left atrial appendage closure has been pursued and, most recently, at least equivalency to anticoagulation was reported in a randomized trial comparing it to conventional anticoagulation with warfarin. This chapter outlines important technical considerations for implantation of a left atrial appendage occlusion device including the currently available WATCHMAN® device (Atritech Inc. Minneapolis, MN, USA) and Amplatzer® Cardiac Plug (AGA Medical Corporation, Minneapolis, MN, USA). It includes important tips regarding imaging, placement, and postprocedural care and outlines future perspectives for the concept of percutaneous left atrial appendage closure.


Atrial Fibrillation Left Atrial Appendage Transseptal Puncture Percutaneous Closure Left Atrial Appendage Thrombus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:755–759PubMedCrossRefGoogle Scholar
  2. 2.
    Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL (2008) Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 52:924–929PubMedCrossRefGoogle Scholar
  3. 3.
    Sievert H, Lesh MD, Trepels T et al (2002) Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105:1887–1889PubMedCrossRefGoogle Scholar
  4. 4.
    Block PC, Burstein S, Casale PN et al (2009) Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2:594–600PubMedCrossRefGoogle Scholar
  5. 5.
    Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542PubMedCrossRefGoogle Scholar
  6. 6.
    Park JW, Bethencourt A, Sievert H et al (2011) Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 77:700–706PubMedCrossRefGoogle Scholar
  7. 7.
    Ostermayer SH, Reisman M, Kramer PH et al (2005) Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 46:9–14PubMedCrossRefGoogle Scholar
  8. 8.
    Guazzi M, Arena R (2009) Endothelial dysfunction and pathophysiological correlates in atrial fibrillation. Heart 95:102–106PubMedCrossRefGoogle Scholar
  9. 9.
    Muller I, Massberg S, Zierhut W et al (2002) Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 32:16–24PubMedCrossRefGoogle Scholar
  10. 10.
    Watson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 373:155–166PubMedCrossRefGoogle Scholar
  11. 11.
    Bruce CJ, Stanton CM, Asirvatham SJ et al (2011) Percutaneous epicardial left atrial appendage closure: intermediate-term results. J Cardiovasc Electrophysiol 22:64–70PubMedCrossRefGoogle Scholar
  12. 12.
    In: Congenital and structural cardiac intervention. Frankfurt, Germany; 2011Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Stefan C. Bertog
    • 1
    • 2
  • Jennifer Franke
    • 1
  • Nina Wunderlich
    • 1
  • Horst Sievert
    • 1
  1. 1.CardioVascular Center FrankfurtFrankfurtGermany
  2. 2.Department of CardiologyMinneapolis Veterans Affairs Medical CenterMinneapolisUSA

Personalised recommendations